XML 27 R17.htm IDEA: XBRL DOCUMENT
v3.25.3

STOCK OPTIONS | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
STOCK OPTIONS | 9. STOCK OPTIONS The Company has a stock option plan (“Plan”). The purpose of this Plan is to provide additional incentives to key employees, officers, directors and consultants of the Company and its subsidiaries in order to help attract and retain the best available personnel for positions of responsibility and otherwise promote the success of the Company’s business. It is intended that options issued under this Plan constitute non-qualified stock options. The general terms of awards under the option plan are that 100% of the options granted will vest the year following the grant unless an executive employee is granted a multi-year stock option grant where an equal amount vests over the next 5 years. The maximum term of options granted is 5 years and the exercise price for all options are issued for not less than fair market value at the date of the grant. The following table summarizes the Company’s stock option activities for the year ended December 31, 2024 and the nine months ended September 30, 2025: SCHEDULE OF STOCK OPTION ACTIVITIES
|  | Number of shares |  |  | Exercise price per share |  |  | Weighted average exercise price |
Balance, December 31, 2023 |  |  | 1,114,000 |  |  | $ | 1.75 – 3.61 |  |  | $ | 3.13 |
Granted |  |  | 1,081,000 |  |  | $ | 2.00 – 4.05 |  |  | $ | 2.12 |
Cancelled or expired |  |  | (275,000 | ) |  | $ | 1.75 – 3.61 |  |  | $ | 2.54 |
Exercised |  |  | (80,000 | ) |  | $ | 1.75 – 2.44 |  |  | $ | 2.31 |
Balance, December 31, 2024 |  |  | 1,840,000 |  |  | $ | 2.00 – 4.05 |  |  | $ | 2.68 |
Cancelled or expired |  |  | (5,034 | ) |  | $ | 2.00 – 3.61 |  |  | $ | 3.24 |
Exercised |  |  | (174,966 | ) |  | $ | 2.00 – 3.61 |  |  | $ | 2.84 |
Balance, September 30, 2025 |  |  | 1,660,000 |  |  | $ | 2.00 – 4.05 |  |  | $ | 2.67 |
Exercisable, September 30, 2025 |  |  | 759,000 |  |  | $ | 2.00 – 3.61 |  |  | $ | 2.69 |
During the three and nine months ended September 30, 2025 and 2024, the Company recognized stock based compensation associated with stock options as follows: SCHEDULE OF RECOGNIZED STOCK BASED COMPENSATION
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Line item on the statement of operations and comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Wages, administrative salaries and benefits |  | $ | 79,739 |  |  | $ | 126,136 |  |  | $ | 239,219 |  |  | $ | 489,421 |
Consulting |  |  | 18,180 |  |  |  | 7,987 |  |  |  | 54,540 |  |  |  | 23,962 |
Stock based compensation |  | $ | 97,919 |  |  | $ | 134,123 |  |  | $ | 293,759 |  |  | $ | 513,383 |
During the nine months ended September 30, 2025, the Company granted nil (2024 – 56,000) stock options to consultants and nil (2024 – 944,000) stock options to employees. The fair value of options granted during 2024 was calculated using the following range of assumptions: SCHEDULE OF STOCK OPTION FAIR VALUE ASSUMPTIONS
|  | 2024 |
Expected life – years |  |  | 3.0 |
Interest rate |  |  | 1.76 – 4.11 | %
Volatility |  |  | 66.01 – 71.59 | %
Fair value of options granted |  |  | $1.46 – 2.02 |
As of September 30, 2025, the weighted-average remaining contractual life of outstanding and exercisable options is 2.8 years and 2.6 years, respectively. As of September 30, 2025, there was approximately $310,092 of compensation expense related to non-vested awards that is expected to be recognized over a weighted average period of 1.2 years. The aggregate intrinsic value of options outstanding and exercisable at September 30, 2025 is $11,573,559 (2024 - $2,022,015) and $5,274,469 (2024 - $637,270), respectively. During the nine months ended September 30, 2025, the intrinsic value of stock options exercised was $687,633 (2024 - $720).

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration